OptiBiotix Health (LON:OPTI) Stock Price Down 2% – Here’s Why

OptiBiotix Health Plc (LON:OPTI) fell 2% during trading on Monday . The company traded as low as GBX 5.50 and last traded at GBX 5.50. 2,352 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 388,060 shares. The stock had previously closed at GBX 5.61.

OptiBiotix Health Stock Performance

The business’s fifty day simple moving average is GBX 6.05 and its 200-day simple moving average is GBX 6.01. The firm has a market capitalization of £5.68 million, a PE ratio of -1.43 and a beta of 1.85.

OptiBiotix Health (LON:OPTI) last released its earnings results on Thursday, May 28th. The company reported GBX (3.84) EPS for the quarter. OptiBiotix Health had a negative return on equity of 52.92% and a negative net margin of 333.62%.The company had revenue of GBX 117 million during the quarter.

Insider Transactions at OptiBiotix Health

In related news, insider David Blain purchased 158,965 shares of the firm’s stock in a transaction on Thursday, May 28th. The shares were acquired at an average price of GBX 6 per share, for a total transaction of £9,537.90. Corporate insiders own 26.79% of the company’s stock.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.